Paucity of Sjögren-like syndrome in a cohort of HIV-1-positive patients in the HAART era. Part II

Rheumatology

Volumn 42, Issue 10, 2003, Pages 1164-1167

  Panayiotakopoulos, G D ^a   Aroni, K ^a   Kyriaki, D ^b   Paikos, S ^b   Vouyioukas, N ^b   Vlachos, A ^b   Kontos, A N ^a   Kordossis, T ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

HAART; HIV infection; Pathology; Sj gren like syndrome

Indexed keywords

ANTIRETROVIRUS AGENT; RNA DIRECTED DNA POLYMERASE INHIBITOR; SULFONYLUREA; TRANQUILIZER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; EUROPEAN UNION; FEMALE; GREECE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATIENT COMPLIANCE; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SALIVARY GLAND BIOPSY; SCREENING TEST; SJOEGREN SYNDROME;

EID: 0141962677     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg316     Document Type: Article

References (13)

1. Dimitrakopoulos AN, Kordossis T, Hatzakis A, Moutsopoulos HM. Mixed cryoglobulinemia in HIV-1 infection: the role of HIV-1. Ann Intern Med 1999; 130:226-30.
2. Kordossis T, Paikos S, Aroni K et al. Prevalence of Sjögren's like syndrome in a cohort of HIV-1 positive patients: descriptive pathology and immunopathology. Br J Rheumatol 1998;37:691-5.
3. Williams FM, Cohen PR, Jumshyd J, Reveille JD. Prevalence of the diffuse infiltrative lymphocytosis syndrome among human immunodeficiency virus type 1-positive outpatients. Arthritis Rheum 1998;41:863-8.
4. McArthur CP, Subtil-DeOliveira A, Palmer D et al. Characteristics of salivary diffuse infiltrative lymphocytosis syndrome in West Africa. Arch Pathol Lab Med 2000;124:1773-9.
5. Kazi S, Cohen PR, Williams F, Schempp R, Reveille JD. The diffuse infiltrative lymphocytosis syndrome: clinical and immunogenetic features in 35 patients. AIDS 1996;10:385-91.
6. Mbopi-Keou FX, Belec L, Teo CG, Scully C, Porter SR. Synergism between HIV and other viruses in the mouth. Lancet Infect Dis 2002;2:416-24.
7. Itescu S, Winchester R. Diffuse infiltrative lymphocytosis syndrome: a disorder occurring in human immunodeficiency virus-1 infection that may present as a sicca syndrome. Rheum Dis Clin North Am 1992;18:683-97.
8. Steinfeld SD, Demols P, Van Voooren JP, Cogan E, Appellboom T. Zidovudine in primary Sjogren's syndrome. Rheumatology 1999;38:814-7.
9. Paton NI, Aboulhab J, Karim F. Hydroxychloroquine, hydroxycarbamide and didanosine as economic treatment for HIV-1. Lancet 2002;11:1667-8.
10. Vitali C, Bombardieri S, Moutsopoulos HM et al. Preliminary criteria for the classification of Sjogren's syndrome. Arthritis Rheum 1993;36:340-7.
11. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41(RR-17):1-19.
12. Greenspan JS, Daniels TE, Talal N, Sylvester RA. The histopathology of Sjogren's syndrome in labial salivary gland biopsies. Oral Surg 1974;37:217-29.
13. Dafni UG, Tzioufas AG, Staikos P, Skopouli FN, Moutsopoulos HM. Prevalence of Sjogren's syndrome in a closed rural community. Ann Rheum Dis 1997;56:521-5.